Colgate Palmolive CO Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
Brian Newman, a Director of Colgate Palmolive Co, received 214 shares of common stock on October 1, 2026.
NYSE
John P Bilbrey, a Director of Colgate Palmolive Co, received 271 shares of common stock on October 1, 2026.
NYSE
Noel R. Wallace, Chairman, President & CEO and a Director of Colgate Palmolive Co, reported multiple transactions in common stock on September 16, 2026.
NYSE
Shane Grant, COO, Americas of Colgate Palmolive Co, reported multiple transactions in common stock on September 16, 2026.
NYSE
Panagiotis Tsourapas, COO, CD, EMEA, APac, Skin of Colgate Palmolive Co, reported multiple transactions in common stock on September 16, 2026.
NYSE
Stanley J Sutula Iii, Chief Financial Officer of Colgate Palmolive Co, reported multiple transactions in common stock on September 16, 2026.
NYSE
John Hazlin, Chief Growth Officer of Colgate Palmolive Co, reported multiple transactions in common stock on September 16, 2026.
NYSE
Sally Massey, Chief People Officer of Colgate Palmolive Co, reported multiple transactions in common stock on September 16, 2026.
NYSE
Betsy Fishbone, CLO and Secretary of Colgate Palmolive Co, reported multiple transactions in common stock on September 16, 2026.
NYSE
Gregory Malcolm, EVP and Controller of Colgate Palmolive Co, reported multiple transactions in common stock on September 16, 2026.
NYSE
Sally Massey, Chief People Officer of Colgate Palmolive Co, reported multiple transactions in common stock on September 11, 2026.
NYSE
Gregory Malcolm, EVP and Controller of Colgate Palmolive Co, reported multiple transactions in common stock on September 11, 2026.
NYSE
John Hazlin, Chief Growth Officer of Colgate Palmolive Co, reported multiple transactions in common stock on September 11, 2026.
NYSE
Shane Grant, COO, Americas of Colgate Palmolive Co, reported a transaction in 622 shares of common stock on September 11, 2026.
NYSE
Betsy Fishbone, CLO and Secretary of Colgate Palmolive Co, reported multiple transactions in common stock on September 11, 2026.
NYSE
Panagiotis Tsourapas, COO, CD, EMEA, APac, Skin of Colgate Palmolive Co, sold 10,000 shares of common stock on August 24, 2026 for $92.05 per share.
NYSE
John T Cahill, a Director of Colgate Palmolive Co, sold 4,170 shares of common stock on August 6, 2026 for $93.37 per share.
NYSE
Noel R. Wallace, Chairman, President & CEO and a Director of Colgate Palmolive Co, sold 322,042 shares of common stock on August 4, 2026.
NYSE
Colgate-Palmolive COO, Americas, Shane Grant, reported a transaction involving the withholding of shares for tax purposes on June 16, 2026.
NYSE
Brian Newman, a Director at Colgate-Palmolive, received an annual stock grant and stock options as part of the company's incentive compensation plan.
NYSE
Kimberly A. Nelson, a Director at Colgate-Palmolive, received an annual stock grant and stock options as part of the company's incentive compensation plan.
NYSE
Martina Hundmejean, a Director at Colgate-Palmolive, received stock grants and options on May 11, 2026, as part of the company's incentive compensation plan.
NYSE
Colgate-Palmolive director Martin C. Harris received stock grants and options as part of the company's annual incentive compensation plan.
NYSE
Colgate-Palmolive reports on director Lorrie M. Norrington's acquisition of common stock and stock options as part of the company's incentive compensation plan.
NYSE
Colgate-Palmolive director Lisa Edwards received an annual stock grant and stock options as part of the company's incentive compensation plan.
NYSE
Colgate-Palmolive Director John T. Cahill was granted 2,075 shares of common stock and 2,424 stock options as part of the company's annual director compensation plan.
NYSE
Colgate-Palmolive Director Christopher S. Boerner received an annual stock grant and stock options as part of the company's incentive compensation plan.
NYSE
John P. Bilbrey, a Director at Colgate-Palmolive, received an annual stock grant and stock options on May 11, 2026, as part of the company's incentive compensation plan.
NYSE
Colgate-Palmolive Chief People Officer Sally Massey reported a sale of 8,599 shares of common stock on May 7, 2026.
NYSE
Colgate-Palmolive Director Lorrie M. Norrington acquired company stock through a deferred compensation plan.